VBI Price To Book Ratio from 2010 to 2024

VBIV Stock  USD 0.60  0.02  3.45%   
VBI Vaccines Price To Book Ratio yearly trend continues to be fairly stable with very little volatility. Price To Book Ratio is likely to outpace its year average in 2024. Price To Book Ratio is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter’s book value per share. View All Fundamentals
 
Price To Book Ratio  
First Reported
2010-12-31
Previous Quarter
1.41
Current Value
1.48
Quarterly Volatility
1.07918342
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check VBI Vaccines financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among VBI main balance sheet or income statement drivers, such as Interest Expense of 8.2 M, Selling General Administrative of 51.6 M or Total Revenue of 8.5 M, as well as many exotic indicators such as Price To Sales Ratio of 102, Dividend Yield of 0.0 or Operating Cycle of 232. VBI financial statements analysis is a perfect complement when working with VBI Vaccines Valuation or Volatility modules.
  
This module can also supplement VBI Vaccines' financial leverage analysis and stock options assessment as well as various VBI Vaccines Technical models . Check out the analysis of VBI Vaccines Correlation against competitors.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.

Latest VBI Vaccines' Price To Book Ratio Growth Pattern

Below is the plot of the Price To Book Ratio of VBI Vaccines over the last few years. It is a ratio used to compare a firm's market value to its book value, calculated by dividing the current closing price of the stock by the latest quarter’s book value per share. VBI Vaccines' Price To Book Ratio historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in VBI Vaccines' overall financial position and show how it may be relating to other accounts over time.
Price To Book Ratio10 Years Trend
Slightly volatile
   Price To Book Ratio   
       Timeline  

VBI Price To Book Ratio Regression Statistics

Arithmetic Mean1.61
Geometric Mean1.06
Coefficient Of Variation67.01
Mean Deviation0.76
Median1.41
Standard Deviation1.08
Sample Variance1.16
Range4.1378
R-Value0.53
Mean Square Error0.90
R-Squared0.28
Significance0.04
Slope0.13
Total Sum of Squares16.30

VBI Price To Book Ratio History

2024 1.48
2023 1.41
2021 4.15
2020 3.5
2019 1.87
2018 1.07
2017 1.57

About VBI Vaccines Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include VBI Vaccines income statement, its balance sheet, and the statement of cash flows. VBI Vaccines investors use historical funamental indicators, such as VBI Vaccines's Price To Book Ratio, to determine how well the company is positioned to perform in the future. Although VBI Vaccines investors may use each financial statement separately, they are all related. The changes in VBI Vaccines's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on VBI Vaccines's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on VBI Vaccines Financial Statements. Understanding these patterns can help to make the right decision on long term investment in VBI Vaccines. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for 2024
Price To Book Ratio 1.41  1.48 
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards VBI Vaccines in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, VBI Vaccines' short interest history, or implied volatility extrapolated from VBI Vaccines options trading.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
When determining whether VBI Vaccines is a strong investment it is important to analyze VBI Vaccines' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact VBI Vaccines' future performance. For an informed investment choice regarding VBI Stock, refer to the following important reports:
Check out the analysis of VBI Vaccines Correlation against competitors.
For more information on how to buy VBI Stock please use our How to Invest in VBI Vaccines guide.
You can also try the Pattern Recognition module to use different Pattern Recognition models to time the market across multiple global exchanges.

Complementary Tools for VBI Stock analysis

When running VBI Vaccines' price analysis, check to measure VBI Vaccines' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy VBI Vaccines is operating at the current time. Most of VBI Vaccines' value examination focuses on studying past and present price action to predict the probability of VBI Vaccines' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move VBI Vaccines' price. Additionally, you may evaluate how the addition of VBI Vaccines to your portfolios can decrease your overall portfolio volatility.
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
AI Investment Finder
Use AI to screen and filter profitable investment opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is VBI Vaccines' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of VBI Vaccines. If investors know VBI will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about VBI Vaccines listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(9.79)
Revenue Per Share
0.689
Quarterly Revenue Growth
19.896
Return On Assets
(0.29)
Return On Equity
(2.20)
The market value of VBI Vaccines is measured differently than its book value, which is the value of VBI that is recorded on the company's balance sheet. Investors also form their own opinion of VBI Vaccines' value that differs from its market value or its book value, called intrinsic value, which is VBI Vaccines' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because VBI Vaccines' market value can be influenced by many factors that don't directly affect VBI Vaccines' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between VBI Vaccines' value and its price as these two are different measures arrived at by different means. Investors typically determine if VBI Vaccines is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, VBI Vaccines' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.